Angelalign Technology (6699.HK) Releases 2025 Results, Clinical Excellence Fuels Global Growth
Angelalign Technology has reported strong financial and operational performance for the fiscal year 2025, underscoring its continued expansion in both domestic and international markets. The company achieved significant growth across key metrics, with total case volume reaching 532,400—an increase of 48.1% year-over-year. Revenue rose to $370.3 million, up 37.8%, while adjusted net income climbed to $43.8 million, marking a notable 63.0% increase. These results reflect Angelalign’s sustained focus on clinical excellence, innovation, and a corporate culture designed to foster collaboration and long-term value creation.
At the core of Angelalign’s success is its commitment to building a highly skilled, globally integrated workforce. CEO Fox Hu emphasized that the clear aligner industry demands not only advanced technical capabilities but also seamless collaboration among professionals across disciplines and geographies. Angelalign’s open and inclusive culture has enabled it to attract top-tier talent who share a passion for delivering high-quality orthodontic solutions. This collaborative environment has become a key driver of the company’s sustained growth and innovation.
A defining element of Angelalign’s strategy has been its direct engagement with leading orthodontists in major global cities. Recognizing that clear aligner treatments are long-term and highly sensitive to variations in product quality and treatment planning, the company chose a challenging but impactful path—earning trust within elite professional circles. Orthodontists often rely on years of experience before adopting new solutions, and their recommendations carry significant weight within the industry. By focusing on these influential practitioners, Angelalign has been able to build credibility and accelerate adoption through professional word-of-mouth.
Over the past three years, the company has invested heavily in strengthening its clinical support systems and service offerings. These efforts have paid off, with Angelalign now enjoying a strong reputation among top orthodontists worldwide. Many practitioners have used Angelalign solutions in hundreds or even thousands of cases, including highly complex treatments. This widespread adoption has contributed to growing recognition of the company’s clinical reliability and treatment predictability, particularly in comparison to competing solutions.
Innovation remains a cornerstone of Angelalign’s value proposition. The company has developed a diverse portfolio of products designed to address real clinical challenges and improve patient outcomes. One of its most notable innovations is the angelButton™ solution, which has been in use for six years and has seen shipments exceed 100 million units globally. This solution is widely praised for its anchorage capabilities and efficiency-enhancing movement protocols, which contribute to more comfortable and predictable treatments. Continuous feedback from clinicians has enabled the company to refine this product, improving both industrial consistency and clinical performance.
Another key innovation is the A6 mandibular advancement solution, which has benefited from over a decade of clinical feedback. This product has demonstrated strong clinical efficacy, particularly in addressing complex orthodontic cases. Angelalign’s approach to innovation is rooted in practicality—it prioritizes solving real-world clinical problems rather than pursuing trends for their own sake. The company recognizes that even the most advanced technologies require long-term validation and iterative improvement to achieve consistent and reliable outcomes.
Collaboration with orthodontists plays a critical role in Angelalign’s research and development process. By incorporating insights from experienced practitioners, the company ensures a steady pipeline of meaningful innovations. This collaborative model is supported by a flexible organizational structure that integrates R&D, clinical support, sales, and operations across more than 60 countries. Angelalign has also established specialized teams focused on training, education, and customer support, ensuring that clinicians receive the guidance needed to achieve optimal results.
To support its global operations, the company has built a robust infrastructure that includes development centers in China, Brazil, and Southeast Asia, as well as manufacturing facilities in China, the United States, and Brazil. These investments enable Angelalign to deliver high-quality products efficiently while maintaining strong compliance, data security, and intellectual property protections.
International markets have emerged as a major growth engine for the company. In 2025, Angelalign recorded 256,200 cases outside mainland China, representing an impressive 82.1% increase. Revenue from these markets reached $163.0 million, up 102.5%. This rapid expansion has been fueled by positive clinical outcomes and endorsements from leading orthodontists, particularly in complex cases. As a result, Angelalign is entering a new phase of growth driven by its professional reputation and global brand recognition.
In China, the company continues to maintain a strong leadership position by expanding its product portfolio and addressing diverse market needs. The domestic clear aligner market is highly fragmented, with significant variation in practitioner expertise, patient demographics, and service models across regions. Angelalign has tailored its approach accordingly, providing comprehensive clinical support and advanced solutions for both urban and underserved markets.
In primary and secondary cities, the company has introduced innovative solutions that combine traditional orthodontics with digital technologies. These include products designed for complex adult cases, such as the Scissors-bite Turbo and Enhanced Curve Turbo, as well as specialized solutions for children and adolescents. These offerings enable more precise and efficient treatments, particularly during critical growth phases. Additionally, Angelalign has enhanced the clinician experience through regular updates to its iOrtho software, improving workflow efficiency and treatment planning accuracy.
In third- and fourth-tier markets, the company is focused on expanding access to high-quality orthodontic care. Through structured training programs and comprehensive support systems, Angelalign helps practitioners deliver consistent and predictable outcomes. This approach not only improves patient care but also strengthens the company’s presence in regions that are often underserved. As some competitors withdraw from these markets, Angelalign has been able to consolidate its leadership position and increase its influence.
Dentists in smaller towns and communities are increasingly recognizing the importance of product quality, treatment planning, and clinical support. Inferior solutions can lead to complications, extended treatment durations, and higher follow-up costs. As awareness grows, many practitioners are opting for premium aligner solutions, further benefiting Angelalign.
In 2025, the company handled 276,200 cases in mainland China, representing a 26.3% increase. Revenue from this market reached $207.3 million, up 10.1%. Beyond financial performance, Angelalign emphasizes the broader impact of its work—ensuring that patients in all regions have access to reliable, high-quality orthodontic treatment.
A significant milestone for the company is the cumulative number of cases it has handled, which has now surpassed 2 million. This achievement reflects not only the scale of its operations but also the complexity of its case portfolio. Many Angelalign treatments involve challenging clinical scenarios, requiring close collaboration among multidisciplinary teams. This collective effort, supported by a strong organizational culture, forms the foundation of the company’s continued success.
Looking ahead, Angelalign remains committed to advancing its capabilities across multiple dimensions. The company plans to further strengthen its corporate culture, invest in technological innovation, and enhance its global clinical support systems. By continuously improving the customer experience and maintaining a focus on clinical excellence, Angelalign aims to sustain its growth trajectory and solidify its position as a leader in the global clear aligner industry.
Through its strategic investments, collaborative approach, and unwavering commitment to quality, Angelalign is well-positioned to navigate the complexities of the orthodontic market and deliver long-term value to patients, practitioners, and stakeholders worldwide.
About Angelalign Technology Inc.
Angelalign Technology Inc., founded in 2003, has already celebrated 2 million satisfied customers. The publicly traded company has a diverse international shareholder base. It offers digital technology-based products and services for clear aligners in more than 60 countries
The original language in which the text is published is the official and authorized version. Translations are provided for convenience only. Only the original language version is legally valid. Therefore, please compare translations with the original language version of the publication.
